0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Cardiac-on-a-Chip Market Research Report 2026
Published Date: 2026-04-08
|
Report Code: QYRE-Auto-32E16998
Home | Market Reports
Global Cardiac on a Chip Market Research Report 2024
BUY CHAPTERS

Global Cardiac-on-a-Chip Market Research Report 2026

Code: QYRE-Auto-32E16998
Report
2026-04-08
Pages:119
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES

Cardiac-on-a-Chip Market Size

The global Cardiac-on-a-Chip market was valued at US$ 1287 million in 2025 and is anticipated to reach US$ 4666 million by 2032, at a CAGR of 20.5% from 2026 to 2032.

Cardiac-on-a-Chip Market

Cardiac-on-a-Chip Market

The 2025 U.S. tariff policies introduce profound uncertainty into the global economic landscape. This report critically examines the implications of recent tariff adjustments and international strategic countermeasures on Cardiac-on-a-Chip competitive dynamics, regional economic interdependencies, and supply chain reconfigurations.
Cardiac-on-a-Chip is a biosimulation technology designed to simulate the structure and function of the human heart. This technology is usually implemented on a microfluidic chip or a microbial chip. Artificially cultured cardiomyocytes are planted on the chip through tissue engineering and biotechnology methods to simulate various characteristics of a real heart, such as myocardial contraction, cardiac electrical activity, etc.
Heart-on-a-chip can be used to simulate cardiac physiology, study the pathogenesis of heart disease, evaluate the efficacy and toxicity of drugs, and develop new treatments for heart disease. This technology provides a highly controllable and reproducible experimental platform for heart-related research, helps understand cardiac physiology and pathology, and accelerates the diagnosis and treatment of heart diseases.
As an emerging market segment in the biomedical field, the cardiac chip market has received widespread attention in recent years. As the global population ages, the prevalence of heart disease increases year by year, which provides a broad space for development of the cardiac chip market. As an innovative medical technology and tool, the market size of cardiac chips is constantly expanding. Cardiac chips have wide applications in many fields, including diagnosis of heart disease, drug screening, toxicity testing, and personalized medicine. By simulating the structure and function of heart tissue, the heart chip can provide a more accurate and efficient experimental platform and promote the research and treatment of heart diseases. Overall, the cardiac chip market has broad development prospects and huge market potential.
This report delivers a comprehensive overview of the global Cardiac-on-a-Chip market, with both quantitative and qualitative analyses, to help readers develop growth strategies, assess the competitive landscape, evaluate their position in the current market, and make informed business decisions regarding Cardiac-on-a-Chip. The Cardiac-on-a-Chip market size, estimates, and forecasts are provided in terms of sales volume (K Units) and revenue (US$ millions), with 2025 as the base year and historical and forecast data for 2021–2032.
The report segments the global Cardiac-on-a-Chip market comprehensively. Regional market sizes by Type, by Application, , and by company are also provided. For deeper insight, the report profiles the competitive landscape, key competitors, and their respective market rankings, and discusses technological trends and new product developments.
This report will assist Cardiac-on-a-Chip manufacturers, new entrants, and companies across the industry value chain with information on revenues, sales volume, and average prices for the overall market and its sub-segments, by company, by Type, by Application, and by region.
Market Segmentation

Scope of Cardiac-on-a-Chip Market Report

Report Metric Details
Report Name Cardiac-on-a-Chip Market
Accounted market size in 2025 US$ 1287 million
Forecasted market size in 2032 US$ 4666 million
CAGR 20.5%
Base Year 2025
Forecasted years 2026 - 2032
Segment by Type
  • Myocardial Chip
  • Heart Tissue Chip
  • Cardiovascular Chip
by Application
  • Pharmaceutical R&D
  • Cardiovascular Disease Research
  • Clinical Diagnosis
Consumption by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia)
  • Asia-Pacific (China, Japan, South Korea, Taiwan)
  • Southeast Asia (India)
  • Latin America (Mexico, Brazil)
By Company Emulate, CN Bio, TissUse, Axion Biosystems, Nortis, InSphero, Mimetas, Ascendance Biotechnology, Tara Biosystems, BioIVT, Hesperos, Zhejiang Ruiao Biotechnology, BGI Genomics
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the scope of the report and presents an executive summary of market segments (by Type, by Application, , etc.), including the size of each segment and its future growth potential. It offers a high-level view of the current market and its likely evolution in the short, medium, and long term.
  • Chapter 2: Provides a detailed analysis of the competitive landscape for Cardiac-on-a-Chip manufacturers, covering pricing, sales and revenue shares, latest development plans, and mergers and acquisitions.
  • Chapter 3: Examines Cardiac-on-a-Chip sales and revenue at the regional and country levels. It quantifies market size and growth potential for each region and its key countries, and outlines market development, outlook, addressable space, and national market size.
  • Chapter 4: Analyzes segments by Type, detailing the size and growth potential of each segment to help readers identify “blue ocean” opportunities.
  • Chapter 5: Analyzes market segments by Application, covering the size and growth potential of each segment to help readers identify “blue ocean” opportunities in downstream markets.
  • Chapter 6: Profiles key players, presenting core information on leading companies, including product sales, revenue, pricing, gross margin, product portfolio/introductions, and recent developments.
  • Chapter 7: Reviews the industry value chain, including upstream and downstream segments.
  • Chapter 8: Discusses market dynamics and recent developments, including drivers, restraints, challenges and risks for manufacturers, U.S. Tariffs and relevant policy analysis.
  • Chapter 9: Summarizes the key findings and conclusions of the report.

FAQ for this report

How fast is Cardiac-on-a-Chip Market growing?

Ans: The Cardiac-on-a-Chip Market witnessing a CAGR of 20.5% during the forecast period 2026-2032.

What is the Cardiac-on-a-Chip Market size in 2032?

Ans: The Cardiac-on-a-Chip Market size in 2032 will be US$ 4666 million.

Who are the main players in the Cardiac-on-a-Chip Market report?

Ans: The main players in the Cardiac-on-a-Chip Market are Emulate, CN Bio, TissUse, Axion Biosystems, Nortis, InSphero, Mimetas, Ascendance Biotechnology, Tara Biosystems, BioIVT, Hesperos, Zhejiang Ruiao Biotechnology, BGI Genomics

What are the Application segmentation covered in the Cardiac-on-a-Chip Market report?

Ans: The Applications covered in the Cardiac-on-a-Chip Market report are Pharmaceutical R&D, Cardiovascular Disease Research, Clinical Diagnosis

What are the Type segmentation covered in the Cardiac-on-a-Chip Market report?

Ans: The Types covered in the Cardiac-on-a-Chip Market report are Myocardial Chip, Heart Tissue Chip, Cardiovascular Chip

1 Cardiac-on-a-Chip Market Overview
1.1 Product Definition
1.2 Cardiac-on-a-Chip by Type
1.2.1 Global Cardiac-on-a-Chip Market Value by Type: 2025 vs 2032
1.2.2 Myocardial Chip
1.2.3 Heart Tissue Chip
1.2.4 Cardiovascular Chip
1.3 Cardiac-on-a-Chip by Application
1.3.1 Global Cardiac-on-a-Chip Market Value by Application: 2025 vs 2032
1.3.2 Pharmaceutical R&D
1.3.3 Cardiovascular Disease Research
1.3.4 Clinical Diagnosis
1.4 Global Cardiac-on-a-Chip Market Size Estimates and Forecasts
1.4.1 Global Cardiac-on-a-Chip Revenue 2021–2032
1.4.2 Global Cardiac-on-a-Chip Sales 2021–2032
1.4.3 Global Cardiac-on-a-Chip Market Average Price (2021–2032)
1.5 Assumptions and Limitations
2 Cardiac-on-a-Chip Market Competition by Manufacturers
2.1 Global Cardiac-on-a-Chip Sales Market Share by Manufacturers (2021–2026)
2.2 Global Cardiac-on-a-Chip Revenue Market Share by Manufacturers (2021–2026)
2.3 Global Cardiac-on-a-Chip Average Price by Manufacturers (2021–2026)
2.4 Global Key Players of Cardiac-on-a-Chip, Industry Ranking, 2023 vs 2024 vs 2025
2.5 Global Key Manufacturers of Cardiac-on-a-Chip, Manufacturing Sites and Headquarters
2.6 Global Key Manufacturers of Cardiac-on-a-Chip, Product Types and Applications
2.7 Global Key Manufacturers of Cardiac-on-a-Chip, Date of Entry into the Industry
2.8 Global Cardiac-on-a-Chip Market Competitive Situation and Trends
2.8.1 Global Cardiac-on-a-Chip Market Concentration Rate
2.8.2 The Top 5 and Top 10 Global Cardiac-on-a-Chip Players Market Share by Revenue
2.8.3 Global Cardiac-on-a-Chip Market Share by Company Tier (Tier 1, Tier 2, Tier 3)
2.9 Manufacturers Mergers & Acquisitions, Expansion Plans
3 Global Cardiac-on-a-Chip Market Scenario by Region
3.1 Global Cardiac-on-a-Chip Market Size by Region: 2021 vs 2025 vs 2032
3.2 Global Cardiac-on-a-Chip Sales by Region: 2021–2032
3.2.1 Global Cardiac-on-a-Chip Sales by Region: 2021–2026
3.2.2 Global Cardiac-on-a-Chip Sales by Region: 2027–2032
3.3 Global Cardiac-on-a-Chip Revenue by Region: 2021–2032
3.3.1 Global Cardiac-on-a-Chip Revenue by Region: 2021–2026
3.3.2 Global Cardiac-on-a-Chip Revenue by Region: 2027–2032
3.4 North America Cardiac-on-a-Chip Market Facts & Figures by Country
3.4.1 North America Cardiac-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.4.2 North America Cardiac-on-a-Chip Sales by Country (2021–2032)
3.4.3 North America Cardiac-on-a-Chip Revenue by Country (2021–2032)
3.4.4 United States
3.4.5 Canada
3.5 Europe Cardiac-on-a-Chip Market Facts & Figures by Country
3.5.1 Europe Cardiac-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.5.2 Europe Cardiac-on-a-Chip Sales by Country (2021–2032)
3.5.3 Europe Cardiac-on-a-Chip Revenue by Country (2021–2032)
3.5.4 Germany
3.5.5 France
3.5.6 U.K.
3.5.7 Italy
3.5.8 Russia
3.6 Asia Pacific Cardiac-on-a-Chip Market Facts & Figures by Region
3.6.1 Asia Pacific Cardiac-on-a-Chip Market Size by Region: 2021 vs 2025 vs 2032
3.6.2 Asia Pacific Cardiac-on-a-Chip Sales by Region (2021–2032)
3.6.3 Asia Pacific Cardiac-on-a-Chip Revenue by Region (2021–2032)
3.6.4 China
3.6.5 Japan
3.6.6 South Korea
3.6.7 India
3.6.8 Australia
3.6.9 China Taiwan
3.6.10 Southeast Asia
3.7 Latin America Cardiac-on-a-Chip Market Facts & Figures by Country
3.7.1 Latin America Cardiac-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.7.2 Latin America Cardiac-on-a-Chip Sales by Country (2021–2032)
3.7.3 Latin America Cardiac-on-a-Chip Revenue by Country (2021–2032)
3.7.4 Mexico
3.7.5 Brazil
3.7.6 Argentina
3.7.7 Colombia
3.8 Middle East and Africa Cardiac-on-a-Chip Market Facts & Figures by Country
3.8.1 Middle East and Africa Cardiac-on-a-Chip Market Size by Country: 2021 vs 2025 vs 2032
3.8.2 Middle East and Africa Cardiac-on-a-Chip Sales by Country (2021–2032)
3.8.3 Middle East and Africa Cardiac-on-a-Chip Revenue by Country (2021–2032)
3.8.4 Turkey
3.8.5 Saudi Arabia
3.8.6 UAE
4 Segment by Type
4.1 Global Cardiac-on-a-Chip Sales by Type (2021–2032)
4.1.1 Global Cardiac-on-a-Chip Sales by Type (2021–2026)
4.1.2 Global Cardiac-on-a-Chip Sales by Type (2027–2032)
4.1.3 Global Cardiac-on-a-Chip Sales Market Share by Type (2021–2032)
4.2 Global Cardiac-on-a-Chip Revenue by Type (2021–2032)
4.2.1 Global Cardiac-on-a-Chip Revenue by Type (2021–2026)
4.2.2 Global Cardiac-on-a-Chip Revenue by Type (2027–2032)
4.2.3 Global Cardiac-on-a-Chip Revenue Market Share by Type (2021–2032)
4.3 Global Cardiac-on-a-Chip Price by Type (2021–2032)
5 Segment by Application
5.1 Global Cardiac-on-a-Chip Sales by Application (2021–2032)
5.1.1 Global Cardiac-on-a-Chip Sales by Application (2021–2026)
5.1.2 Global Cardiac-on-a-Chip Sales by Application (2027–2032)
5.1.3 Global Cardiac-on-a-Chip Sales Market Share by Application (2021–2032)
5.2 Global Cardiac-on-a-Chip Revenue by Application (2021–2032)
5.2.1 Global Cardiac-on-a-Chip Revenue by Application (2021–2026)
5.2.2 Global Cardiac-on-a-Chip Revenue by Application (2027–2032)
5.2.3 Global Cardiac-on-a-Chip Revenue Market Share by Application (2021–2032)
5.3 Global Cardiac-on-a-Chip Price by Application (2021–2032)
6 Key Companies Profiled
6.1 Emulate
6.1.1 Emulate Company Information
6.1.2 Emulate Description and Business Overview
6.1.3 Emulate Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.1.4 Emulate Cardiac-on-a-Chip Product Portfolio
6.1.5 Emulate Recent Developments/Updates
6.2 CN Bio
6.2.1 CN Bio Company Information
6.2.2 CN Bio Description and Business Overview
6.2.3 CN Bio Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.2.4 CN Bio Cardiac-on-a-Chip Product Portfolio
6.2.5 CN Bio Recent Developments/Updates
6.3 TissUse
6.3.1 TissUse Company Information
6.3.2 TissUse Description and Business Overview
6.3.3 TissUse Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.3.4 TissUse Cardiac-on-a-Chip Product Portfolio
6.3.5 TissUse Recent Developments/Updates
6.4 Axion Biosystems
6.4.1 Axion Biosystems Company Information
6.4.2 Axion Biosystems Description and Business Overview
6.4.3 Axion Biosystems Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.4.4 Axion Biosystems Cardiac-on-a-Chip Product Portfolio
6.4.5 Axion Biosystems Recent Developments/Updates
6.5 Nortis
6.5.1 Nortis Company Information
6.5.2 Nortis Description and Business Overview
6.5.3 Nortis Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.5.4 Nortis Cardiac-on-a-Chip Product Portfolio
6.5.5 Nortis Recent Developments/Updates
6.6 InSphero
6.6.1 InSphero Company Information
6.6.2 InSphero Description and Business Overview
6.6.3 InSphero Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.6.4 InSphero Cardiac-on-a-Chip Product Portfolio
6.6.5 InSphero Recent Developments/Updates
6.7 Mimetas
6.7.1 Mimetas Company Information
6.7.2 Mimetas Description and Business Overview
6.7.3 Mimetas Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.7.4 Mimetas Cardiac-on-a-Chip Product Portfolio
6.7.5 Mimetas Recent Developments/Updates
6.8 Ascendance Biotechnology
6.8.1 Ascendance Biotechnology Company Information
6.8.2 Ascendance Biotechnology Description and Business Overview
6.8.3 Ascendance Biotechnology Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.8.4 Ascendance Biotechnology Cardiac-on-a-Chip Product Portfolio
6.8.5 Ascendance Biotechnology Recent Developments/Updates
6.9 Tara Biosystems
6.9.1 Tara Biosystems Company Information
6.9.2 Tara Biosystems Description and Business Overview
6.9.3 Tara Biosystems Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.9.4 Tara Biosystems Cardiac-on-a-Chip Product Portfolio
6.9.5 Tara Biosystems Recent Developments/Updates
6.10 BioIVT
6.10.1 BioIVT Company Information
6.10.2 BioIVT Description and Business Overview
6.10.3 BioIVT Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.10.4 BioIVT Cardiac-on-a-Chip Product Portfolio
6.10.5 BioIVT Recent Developments/Updates
6.11 Hesperos
6.11.1 Hesperos Company Information
6.11.2 Hesperos Description and Business Overview
6.11.3 Hesperos Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.11.4 Hesperos Cardiac-on-a-Chip Product Portfolio
6.11.5 Hesperos Recent Developments/Updates
6.12 Zhejiang Ruiao Biotechnology
6.12.1 Zhejiang Ruiao Biotechnology Company Information
6.12.2 Zhejiang Ruiao Biotechnology Description and Business Overview
6.12.3 Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.12.4 Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Product Portfolio
6.12.5 Zhejiang Ruiao Biotechnology Recent Developments/Updates
6.13 BGI Genomics
6.13.1 BGI Genomics Company Information
6.13.2 BGI Genomics Description and Business Overview
6.13.3 BGI Genomics Cardiac-on-a-Chip Sales, Revenue, and Gross Margin (2021–2026)
6.13.4 BGI Genomics Cardiac-on-a-Chip Product Portfolio
6.13.5 BGI Genomics Recent Developments/Updates
7 Industry Chain and Sales Channels Analysis
7.1 Cardiac-on-a-Chip Industry Chain Analysis
7.2 Cardiac-on-a-Chip Raw Material Supply Analysis
7.2.1 Key Raw Materials
7.2.2 Raw Materials Key Suppliers
7.3 Cardiac-on-a-Chip Production Mode & Process Analysis
7.4 Cardiac-on-a-Chip Sales and Marketing
7.4.1 Cardiac-on-a-Chip Sales Channels
7.4.2 Cardiac-on-a-Chip Distributors
7.5 Cardiac-on-a-Chip Customer Analysis
8 Cardiac-on-a-Chip Market Dynamics
8.1 Cardiac-on-a-Chip Industry Trends
8.2 Cardiac-on-a-Chip Market Drivers
8.3 Cardiac-on-a-Chip Market Challenges
8.4 Cardiac-on-a-Chip Market Restraints
8.5 Impact of U.S. Tariffs
9 Research Findings and Conclusion
10 Methodology and Data Source
10.1 Methodology/Research Approach
10.1.1 Research Programs/Design
10.1.2 Market Size Estimation
10.1.3 Market Breakdown and Data Triangulation
10.2 Data Source
10.2.1 Secondary Sources
10.2.2 Primary Sources
10.3 Author List
10.4 Disclaimer
List of Tables
 Table 1. Global Cardiac-on-a-Chip Market Value by Type (US$ Million), 2025 vs 2032
 Table 2. Global Cardiac-on-a-Chip Market Value by Application (US$ Million), 2025 vs 2032
 Table 3. Global Cardiac-on-a-Chip Market Competitive Situation by Manufacturers in 2025
 Table 4. Global Cardiac-on-a-Chip Sales (K Units) of Key Manufacturers (2021–2026)
 Table 5. Global Cardiac-on-a-Chip Sales Market Share by Manufacturers (2021–2026)
 Table 6. Global Cardiac-on-a-Chip Revenue (US$ Million) by Manufacturers (2021–2026)
 Table 7. Global Cardiac-on-a-Chip Revenue Share by Manufacturers (2021–2026)
 Table 8. Global Market Cardiac-on-a-Chip Average Price (US$/Unit) of Key Manufacturers (2021–2026)
 Table 9. Global Key Players of Cardiac-on-a-Chip, Industry Ranking, 2023 vs 2024 vs 2025
 Table 10. Global Key Manufacturers of Cardiac-on-a-Chip, Manufacturing Sites and Headquarters
 Table 11. Global Key Manufacturers of Cardiac-on-a-Chip, Product Types and Applications
 Table 12. Global Key Manufacturers of Cardiac-on-a-Chip, Date of Entry into the Industry
 Table 13. Global Manufacturers Market Concentration Ratio (CR5 and HHI)
 Table 14. Global Cardiac-on-a-Chip Companies by Tier (Tier 1, Tier 2, Tier 3), based on Cardiac-on-a-Chip Revenue, 2025
 Table 15. Manufacturers Mergers & Acquisitions, Expansion Plans
 Table 16. Global Cardiac-on-a-Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Table 17. Global Cardiac-on-a-Chip Sales by Region (K Units), 2021–2026
 Table 18. Global Cardiac-on-a-Chip Sales Market Share by Region (2021–2026)
 Table 19. Global Cardiac-on-a-Chip Sales by Region (K Units), 2027–2032
 Table 20. Global Cardiac-on-a-Chip Sales Market Share by Region (2027–2032)
 Table 21. Global Cardiac-on-a-Chip Revenue by Region (US$ Million), 2021–2026
 Table 22. Global Cardiac-on-a-Chip Revenue Market Share by Region (2021–2026)
 Table 23. Global Cardiac-on-a-Chip Revenue by Region (US$ Million), 2027–2032
 Table 24. Global Cardiac-on-a-Chip Revenue Market Share by Region (2027–2032)
 Table 25. North America Cardiac-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 26. North America Cardiac-on-a-Chip Sales by Country (K Units), 2021–2026
 Table 27. North America Cardiac-on-a-Chip Sales by Country (K Units), 2027–2032
 Table 28. North America Cardiac-on-a-Chip Revenue by Country (US$ Million), 2021–2026
 Table 29. North America Cardiac-on-a-Chip Revenue by Country (US$ Million), 2027–2032
 Table 30. Europe Cardiac-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 31. Europe Cardiac-on-a-Chip Sales by Country (K Units), 2021–2026
 Table 32. Europe Cardiac-on-a-Chip Sales by Country (K Units), 2027–2032
 Table 33. Europe Cardiac-on-a-Chip Revenue by Country (US$ Million), 2021–2026
 Table 34. Europe Cardiac-on-a-Chip Revenue by Country (US$ Million), 2027–2032
 Table 35. Asia Pacific Cardiac-on-a-Chip Revenue by Region: 2021 vs 2025 vs 2032 (US$ Million)
 Table 36. Asia Pacific Cardiac-on-a-Chip Sales by Region (K Units), 2021–2026
 Table 37. Asia Pacific Cardiac-on-a-Chip Sales by Region (K Units), 2027–2032
 Table 38. Asia Pacific Cardiac-on-a-Chip Revenue by Region (US$ Million), 2021–2026
 Table 39. Asia Pacific Cardiac-on-a-Chip Revenue by Region (US$ Million), 2027–2032
 Table 40. Latin America Cardiac-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 41. Latin America Cardiac-on-a-Chip Sales by Country (K Units), 2021–2026
 Table 42. Latin America Cardiac-on-a-Chip Sales by Country (K Units), 2027–2032
 Table 43. Latin America Cardiac-on-a-Chip Revenue by Country (US$ Million), 2021–2026
 Table 44. Latin America Cardiac-on-a-Chip Revenue by Country (US$ Million), 2027–2032
 Table 45. Middle East and Africa Cardiac-on-a-Chip Revenue by Country: 2021 vs 2025 vs 2032 (US$ Million)
 Table 46. Middle East and Africa Cardiac-on-a-Chip Sales by Country (K Units), 2021–2026
 Table 47. Middle East and Africa Cardiac-on-a-Chip Sales by Country (K Units), 2027–2032
 Table 48. Middle East and Africa Cardiac-on-a-Chip Revenue by Country (US$ Million), 2021–2026
 Table 49. Middle East and Africa Cardiac-on-a-Chip Revenue by Country (US$ Million), 2027–2032
 Table 50. Global Cardiac-on-a-Chip Sales (K Units) by Type (2021–2026)
 Table 51. Global Cardiac-on-a-Chip Sales (K Units) by Type (2027–2032)
 Table 52. Global Cardiac-on-a-Chip Sales Market Share by Type (2021–2026)
 Table 53. Global Cardiac-on-a-Chip Sales Market Share by Type (2027–2032)
 Table 54. Global Cardiac-on-a-Chip Revenue (US$ Million) by Type (2021–2026)
 Table 55. Global Cardiac-on-a-Chip Revenue (US$ Million) by Type (2027–2032)
 Table 56. Global Cardiac-on-a-Chip Revenue Market Share by Type (2021–2026)
 Table 57. Global Cardiac-on-a-Chip Revenue Market Share by Type (2027–2032)
 Table 58. Global Cardiac-on-a-Chip Price (US$/Unit) by Type (2021–2026)
 Table 59. Global Cardiac-on-a-Chip Price (US$/Unit) by Type (2027–2032)
 Table 60. Global Cardiac-on-a-Chip Sales (K Units) by Application (2021–2026)
 Table 61. Global Cardiac-on-a-Chip Sales (K Units) by Application (2027–2032)
 Table 62. Global Cardiac-on-a-Chip Sales Market Share by Application (2021–2026)
 Table 63. Global Cardiac-on-a-Chip Sales Market Share by Application (2027–2032)
 Table 64. Global Cardiac-on-a-Chip Revenue (US$ Million) by Application (2021–2026)
 Table 65. Global Cardiac-on-a-Chip Revenue (US$ Million) by Application (2027–2032)
 Table 66. Global Cardiac-on-a-Chip Revenue Market Share by Application (2021–2026)
 Table 67. Global Cardiac-on-a-Chip Revenue Market Share by Application (2027–2032)
 Table 68. Global Cardiac-on-a-Chip Price (US$/Unit) by Application (2021–2026)
 Table 69. Global Cardiac-on-a-Chip Price (US$/Unit) by Application (2027–2032)
 Table 70. Emulate Company Information
 Table 71. Emulate Description and Business Overview
 Table 72. Emulate Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 73. Emulate Cardiac-on-a-Chip Product
 Table 74. Emulate Recent Developments/Updates
 Table 75. CN Bio Company Information
 Table 76. CN Bio Description and Business Overview
 Table 77. CN Bio Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 78. CN Bio Cardiac-on-a-Chip Product
 Table 79. CN Bio Recent Developments/Updates
 Table 80. TissUse Company Information
 Table 81. TissUse Description and Business Overview
 Table 82. TissUse Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 83. TissUse Cardiac-on-a-Chip Product
 Table 84. TissUse Recent Developments/Updates
 Table 85. Axion Biosystems Company Information
 Table 86. Axion Biosystems Description and Business Overview
 Table 87. Axion Biosystems Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 88. Axion Biosystems Cardiac-on-a-Chip Product
 Table 89. Axion Biosystems Recent Developments/Updates
 Table 90. Nortis Company Information
 Table 91. Nortis Description and Business Overview
 Table 92. Nortis Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 93. Nortis Cardiac-on-a-Chip Product
 Table 94. Nortis Recent Developments/Updates
 Table 95. InSphero Company Information
 Table 96. InSphero Description and Business Overview
 Table 97. InSphero Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 98. InSphero Cardiac-on-a-Chip Product
 Table 99. InSphero Recent Developments/Updates
 Table 100. Mimetas Company Information
 Table 101. Mimetas Description and Business Overview
 Table 102. Mimetas Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 103. Mimetas Cardiac-on-a-Chip Product
 Table 104. Mimetas Recent Developments/Updates
 Table 105. Ascendance Biotechnology Company Information
 Table 106. Ascendance Biotechnology Description and Business Overview
 Table 107. Ascendance Biotechnology Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 108. Ascendance Biotechnology Cardiac-on-a-Chip Product
 Table 109. Ascendance Biotechnology Recent Developments/Updates
 Table 110. Tara Biosystems Company Information
 Table 111. Tara Biosystems Description and Business Overview
 Table 112. Tara Biosystems Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 113. Tara Biosystems Cardiac-on-a-Chip Product
 Table 114. Tara Biosystems Recent Developments/Updates
 Table 115. BioIVT Company Information
 Table 116. BioIVT Description and Business Overview
 Table 117. BioIVT Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 118. BioIVT Cardiac-on-a-Chip Product
 Table 119. BioIVT Recent Developments/Updates
 Table 120. Hesperos Company Information
 Table 121. Hesperos Description and Business Overview
 Table 122. Hesperos Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 123. Hesperos Cardiac-on-a-Chip Product
 Table 124. Hesperos Recent Developments/Updates
 Table 125. Zhejiang Ruiao Biotechnology Company Information
 Table 126. Zhejiang Ruiao Biotechnology Description and Business Overview
 Table 127. Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 128. Zhejiang Ruiao Biotechnology Cardiac-on-a-Chip Product
 Table 129. Zhejiang Ruiao Biotechnology Recent Developments/Updates
 Table 130. BGI Genomics Company Information
 Table 131. BGI Genomics Description and Business Overview
 Table 132. BGI Genomics Cardiac-on-a-Chip Sales (K Units), Revenue (US$ Million), Price (US$/Unit), and Gross Margin (2021–2026)
 Table 133. BGI Genomics Cardiac-on-a-Chip Product
 Table 134. BGI Genomics Recent Developments/Updates
 Table 135. Key Raw Materials Lists
 Table 136. Raw Materials Key Suppliers Lists
 Table 137. Cardiac-on-a-Chip Distributors List
 Table 138. Cardiac-on-a-Chip Customers List
 Table 139. Cardiac-on-a-Chip Market Trends
 Table 140. Cardiac-on-a-Chip Market Drivers
 Table 141. Cardiac-on-a-Chip Market Challenges
 Table 142. Cardiac-on-a-Chip Market Restraints
 Table 143. Research Programs/Design for This Report
 Table 144. Key Data Information from Secondary Sources
 Table 145. Key Data Information from Primary Sources
 Table 146. Authors List of This Report


List of Figures
 Figure 1. Product Picture of Cardiac-on-a-Chip
 Figure 2. Global Cardiac-on-a-Chip Market Value by Type (US$ Million), 2021–2032
 Figure 3. Global Cardiac-on-a-Chip Market Share by Type: 2025 & 2032
 Figure 4. Myocardial Chip Product Picture
 Figure 5. Heart Tissue Chip Product Picture
 Figure 6. Cardiovascular Chip Product Picture
 Figure 7. Global Cardiac-on-a-Chip Market Value by Application (US$ Million), 2021–2032
 Figure 8. Global Cardiac-on-a-Chip Market Share by Application: 2025 & 2032
 Figure 9. Pharmaceutical R&D
 Figure 10. Cardiovascular Disease Research
 Figure 11. Clinical Diagnosis
 Figure 12. Global Cardiac-on-a-Chip Revenue, (US$ Million), 2021 vs 2025 vs 2032
 Figure 13. Global Cardiac-on-a-Chip Market Size (US$ Million), 2021–2032
 Figure 14. Global Cardiac-on-a-Chip Sales (K Units), 2021–2032
 Figure 15. Global Cardiac-on-a-Chip Average Price (US$/Unit), 2021–2032
 Figure 16. Cardiac-on-a-Chip Report Years Considered
 Figure 17. Cardiac-on-a-Chip Sales Share by Manufacturers in 2025
 Figure 18. Global Cardiac-on-a-Chip Revenue Share by Manufacturers in 2025
 Figure 19. Top 5 and Top 10 Global Cardiac-on-a-Chip Players: Market Share by Revenue in Cardiac-on-a-Chip in 2025
 Figure 20. Cardiac-on-a-Chip Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2021 vs 2025
 Figure 21. Global Cardiac-on-a-Chip Market Size by Region (US$ Million): 2021 vs 2025 vs 2032
 Figure 22. North America Cardiac-on-a-Chip Sales Market Share by Country (2021–2032)
 Figure 23. North America Cardiac-on-a-Chip Revenue Market Share by Country (2021–2032)
 Figure 24. United States Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 25. Canada Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 26. Europe Cardiac-on-a-Chip Sales Market Share by Country (2021–2032)
 Figure 27. Europe Cardiac-on-a-Chip Revenue Market Share by Country (2021–2032)
 Figure 28. Germany Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 29. France Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 30. U.K. Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 31. Italy Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 32. Russia Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 33. Asia Pacific Cardiac-on-a-Chip Sales Market Share by Region (2021–2032)
 Figure 34. Asia Pacific Cardiac-on-a-Chip Revenue Market Share by Region (2021–2032)
 Figure 35. China Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 36. Japan Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 37. South Korea Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 38. India Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 39. Australia Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 40. China Taiwan Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 41. Southeast Asia Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 42. Latin America Cardiac-on-a-Chip Sales Market Share by Country (2021–2032)
 Figure 43. Latin America Cardiac-on-a-Chip Revenue Market Share by Country (2021–2032)
 Figure 44. Mexico Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 45. Brazil Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 46. Argentina Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 47. Colombia Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 48. Middle East and Africa Cardiac-on-a-Chip Sales Market Share by Country (2021–2032)
 Figure 49. Middle East and Africa Cardiac-on-a-Chip Revenue Market Share by Country (2021–2032)
 Figure 50. Turkey Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 51. Saudi Arabia Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 52. UAE Cardiac-on-a-Chip Revenue Growth Rate (US$ Million), 2021–2032
 Figure 53. Global Sales Market Share of Cardiac-on-a-Chip by Type (2021–2032)
 Figure 54. Global Revenue Market Share of Cardiac-on-a-Chip by Type (2021–2032)
 Figure 55. Global Cardiac-on-a-Chip Price (US$/Unit) by Type (2021–2032)
 Figure 56. Global Sales Market Share of Cardiac-on-a-Chip by Application (2021–2032)
 Figure 57. Global Revenue Market Share of Cardiac-on-a-Chip by Application (2021–2032)
 Figure 58. Global Cardiac-on-a-Chip Price (US$/Unit) by Application (2021–2032)
 Figure 59. Cardiac-on-a-Chip Value Chain
 Figure 60. Channels of Distribution (Direct Vs Distribution)
 Figure 61. Bottom-up and Top-down Approaches for This Report
 Figure 62. Data Triangulation
 Figure 63. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic

$2900

Single User License
Electronic

$4350

Multi User License
Electronic

$5800

Enterprise License
Add to Cart
Buy Now (15% Discount)

OUR CUSTOMER

Nano String